Dotmatics Supports AWS’ Health Initiative for Lab Efficiency
Dotmatics has joined AWS for Health to enhance laboratory efficiency and accelerate scientific innovation by providing cloud-based, real-time, integrated informatics software that automates data workflows and facilitates seamless, error-reducing data exchange among global scientific collaborators in healthcare, biopharma, and genomics.
Dotmatics, a scientific informatics software and services company focused on automating laboratory data workflows for scientific discovery and innovation research, has announced its support for the AWS for Health initiative from Amazon Web Services (AWS). This initiative aims to improve laboratory efficiency and accelerate scientific innovation by enabling more rapid data access, analysis, and exchange among scientists globally.
AWS for Health features services and solutions from AWS and its partners, specifically designed for healthcare, biopharma, and genomics customers. The initiative helps health customers select the right tools and partners for their most critical workloads. It also provides access to AWS health industry specialists, AWS Professional Services teams, and leading AWS Partners in each solution area for customers seeking solution-specific support.
Modern research projects often involve collaborative networks across pharmaceutical, biotech, academic, and contract research organizations (CROs). Traditional methods of sharing results and work requests—such as email, file shares, and reports—can delay research cycles and introduce errors in data transcription and interpretation, ultimately slowing innovation. Effective cross-team projects require real-time scientific data exchange to support informed project decisions. Additionally, the increasing volume and complexity of data from high-throughput experimentation necessitate workflow automation to ensure clean data is available for advanced analytics, including Artificial Intelligence (AI) and Machine Learning.
Dotmatics’ cloud-based software offers simple, unified, real-time access to all research data in both its own and third-party databases. It provides integrated, scientifically aware informatics solutions for small molecule and biologics discovery, expediting scientific workflows and enabling automation of instrument data acquisition and processing. This allows in-house or multi-organizational research teams to operate more efficiently.
Powered by AWS, the Dotmatics Platform benefits from the security, scalability, and agility of the cloud. It provides a single point of access to all scientific data and functions across multidisciplinary groups. The platform's flexibility allows scientists, collaborators, and partners to interact with the same data via the cloud, regardless of location or time zone, enabling real-time research. Customers can quickly deploy a Dotmatics environment using their own Amazon Elastic Compute Cloud (Amazon EC2) instance through the AWS Quick Start Biotech Blueprint.
Alastair Hill, Co-Founder and CIO of Dotmatics, stated:
Our cloud-based systems are designed to provide real-time access to all scientific project data coupled with powerful analytics and visualisation, for all team members irrespective of location. An accessible and secure data foundation is key to improving innovation through better-informed decision-making for scientists, aided by next generation AI and machine learning. We are delighted to be part of the AWS for Health initiative which brings together the best in the industry, making it easy for healthcare, biopharma, and genomics customers to find, test, buy, and deploy software that runs on AWS.
For more information, visit:
Related
Addressing Inefficient R&D Workflows
The blog discusses how legacy, fragmented R&D systems hinder innovation in complex, multi-domain scientific research by creating silos and inefficiencies, and presents Dotmatics’ unifying platform as a comprehensive solution that integrates diverse tools, data, and teams to enable smarter collaboration, governed data use, and AI-driven automation for faster, more rigorous innovation.
Dotmatics Set to Transform the Future of Scientific Software and Data Management
Dotmatics, formed from the merger of Insightful Science and Dotmatics, is launching a powerful integrated enterprise R&D platform combining its scientific software with popular applications like SnapGene, Geneious, and GraphPad Prism to address complex data challenges and accelerate scientific research and collaboration for over two million scientists and 10,000 customers worldwide.
Scientific Workflow Software
Dotmatics is a global leader in R&D scientific software that digitizes and automates lab workflows to provide high-quality data access, supports multimodal drug discovery across biology and chemistry, integrates best-in-breed applications like GraphPad Prism and SnapGene, and addresses informatics challenges that compromise 80% of scientists' data outputs and 2/3 of their decision-making, enabling over 2 million researchers to accelerate life-changing discoveries.
Luma Platform Overview
Luma is a versatile multimodal scientific intelligence platform that supports diverse scientific disciplines and techniques by enabling low-code app creation with configurable workflows, data integration, AI/ML capabilities, and secure governance, facilitating scientific discovery and R&D across fields such as drug discovery, materials science, and biotechnology through adaptive, API-driven infrastructure and tailored user experiences.
USA Today: How Dotmatics is Powering the AI-Driven Future of Drug Discovery
The USA Today article highlights Dotmatics as a pivotal force in the AI-driven transformation of drug discovery, emphasizing its cloud-based data management platform and the launch of Luma, a multimodal drug discovery platform that enhances scientific innovation and R&D efficiency.
Our 11 Most-Read Blogs of 2023: AI, Biologics, ELNs, and More
Dotmatics' top blogs of 2023 highlight key scientific advancements including the convergence of small molecule and biologic drug development, the integration and comparison of LIMS and ELN systems for enhanced lab data management, and strategies to minimize human errors in biologics research through automation and calibration.